T.U. Federation of Chemical, Glass and Ceramic
Industries in Poland.
Józef Woźny- President

National Pharmaceutical Industry plays an important role in the
Polish health & care system provides patients with affordable
medicines available to treat most illnesses.
It also has a great importance for the economy of
providing 55% of the medicines sold in Poland.

Polish pharmaceutical industry is one of the largest generic
medicines producer in Europe.
It provides public access to medicines of good quality with
benefit price (more than 50% of the packages in the market
comes from domestic plants).
18
16
14
17.1
14.6
13.312.9
12.6
12
10
8
6
4
2
0
10.0
9.2 9.0
8.3
7.1
6.6 6.5 6.4
5.9 5.9
4.7 4.5
4.2
3.6
3.0
Valuable
Quantitative
Oryginal
Generic
Privatization process:
Polfa Poznań
GlaxoSmithKline
Polfa Rzeszów
Valeant (formerly ICN)
Polfa Kraków
Pliva /Teva
Polfa Grodzisk
Gedeon Richter
Polfa Kutno
Teva
Fabryka w Starogardzie
Gdańskim
National invetor- Jerzy
Starak
Polfa Pabianice
National companyAdamed
Only one plant-Polfa Tarchomin remains in the hands of the Treasury.
Domestic pharmaceutical companies more than 60% of the profit is investing.
These investments have allowed companies such as for:





Process to complete implementation of Quality Management Systems,
implementation of Good Manufacturing Practice (GMP),
the adjustment of medicines documents with European Union
requirements,
employment restructuring, development cooperation programs in science,
increase in the number of patents, the development of biotechnology,
the adaptation of production to high standards of environmental
protection.
Domestic pharmaceutical companies spend on research and development,
13% of the profits, where the average for the processing industry
in Poland is 3.5%.
The export of medicines to EU countries are 75.6%.
Among the countries to which exported the Polish
medicine complex, the majority were:
Germany (15.5% of Polish exports) and the United
Kingdom,
France and Russia (about 9% of Polish foreign
sales).
Domestic pharmaceutical industry employs approx. 23 000 peoples.
Salary in the manufacturing industry was
in the pharmaceutical industry
3 250.00 PLN
5 319.00 PLN.
Trade Union membership in the pharmaceutical industry is in
the range of 30-35%.
In the factories functioning Works Collective Labour
Agreements.
Where are the European Works Council representatives of
Polish pharmaceutical companies are authorized.
Works Council functioning of each plant.
Multi-establishment collective agreement is not signed, has not
given its consent Employers Association of Pharmaceutical
Industries.
Charitable activities
Sponsoring of sport and cultural news
Organized of seminars and science conferences
Information actions for the patients
Investments in environmental
Free diagnostics for patients
Other
Companies don’t take activities on this field.
The introduction a new products in market
The overall increase in wealth of the society
The access to reimbursement
The access to investment funds
Improving the law system
The marketing actions
Improving quality of products
Output from outside the polish market
Increasing health consciousness of Poles
Increasing of amount of sales representatives
THANK YOU FOR ATTENTION !
Presentation prepared on the basis of the documentation:
1. Polish Employers Association in the Pharmaceutical Industry
2. Department of Economic Information- Invest In Poland
3. T.U. Federation of Chemical, Glass and Ceramic Industries in Poland